Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

OssDsign AB (publ) publishes Q3 2026 interim report

OSSDRegulatory press release03.11.2026, 07.00
Download the release

Focused on the levers for sales growth

OssDsign AB (publ) announces that the interim report for Q3 2026 is now available as a PDF on the company's website www.ossdsign.com/reports. A PDF version is also attached to this press release.

 

The Q3 2026 results will also be presented at an investor webcast today November 3rd at 11:00 CEST. The webcast can be accessed via the following link: https://access.dnbcarnegie.com/companies/1392/live or via the OssDsign website.  

 

 

The third quarter in figures

  • Net sales amounted to TSEK 35,728 (44,020), which translates to an 8.2% decrease quarter-over-quarter with constant exchange rates, or 5.4% decrease in reported figures. This was in line with our expectations, as we commented during our Q2 release.
  • Gross margin of 93.2% is an improvement over 92.1% in the previous quarter of 2026 but below 95.6% in the third quarter of the previous year. Some improvement in product and customer mix compared to the previous quarter.
  • Adjusted EBIT of TSEK -6,615 (-5,319), with the reduction in operating expenses compensating for most of the gross profit shortfall.
  • Reported EBIT of TSEK -6,863 (-5,533).
  • Operating expenses were lower than last year with sales variable costs at 49.9% (48.7%) of net sales in the period.
  • Net result for the period amounted to TSEK -5,776 (-5,781).
  • Earnings per share of SEK -0.1 (-0.1).
  • Cash flow from operating activities of TSEK -5,255 (-9,379), better than last year due to the favorable working capital development.

 

The first nine months in figures

  • Net sales amounted to TSEK 110,383 (135,036), which translates to a 13.6% decrease with constant exchange rates, or 18.3% in reported figures.
  • Gross margin of 92.3% (96.3%), negatively affected by product and customer mix.
  • Adjusted EBIT of TSEK -31,979 (-17,086), as a direct consequence of the lower sales and gross margin, with some mitigation from the lower operating expenses.
  • Reported EBIT of TSEK -32,677 (-25,167).
  • Operating expenses were lower than last year and sales variable costs were down to 47.2% (48.9%) of net sales in the period.
  • Net result for the period amounted to TSEK -28,658 (-28,699).
  • Earnings per share of SEK -0.3 (-0.3).
  • Cash flow from operating activities of TSEK -31,932 (-47,148), due to the favorable working capital development in the first nine months of 2026.

  

Significant events during the third quarter

  • OssDsign surpasses 400 patients in PROPEL spine registry evaluating OssDsign Catalyst®.

 

Significant events after the end of the third quarter

  • There were no significant events after the end of the third quarter.

 

 

  

This disclosure contains information that OssDsign AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 03-11-2026 07:00 CET.